WHO approves trials for two new Ebola vaccines
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"WHO approves trials for two new Ebola vaccines" is generating significant coverage in the Health category, with 15 articles from 13 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Independent, CIDRAP, Health Policy Watch and Democracy Now!. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 8d ago.
Quick answers
Why is "WHO approves trials for two new Ebola vaccines" trending?
Because 13 independent news sources published 15 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (15)
- Is there a vaccine for Ebola? The treatments being developed for the Bundibugyo strain The Independent · 10d ago
- As Ebola cases near 10,700, WHO recommends adding 2 Bundibugyo vaccines to clinical trial CIDRAP · 10d ago
- WHO Greenlights Two Ebola Bundibugyo Virus Vaccine Candidates For Phase 2/3 Trials Health Policy Watch · 10d ago
- World Health Organization Approves Trials of Two New Ebola Vaccines Democracy Now! · 10d ago
- Two new Ebola vaccines to join DR Congo clinical trial UN News · 10d ago
- Ebola Bundibugyo IFPMA · 10d ago
- Moderna (MRNA) After WHO Vaccine Backing Looks Pricey Despite The Rally Yahoo Finance · 10d ago
- WHO backs trials for two new vaccines against Ebola outbreak Euronews.com · 10d ago
- WHO approves trials of two Ebola vaccines in the DRC UA.NEWS · 10d ago
- Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study Yahoo Finance · 10d ago
- The treatments being developed for the Bundibugyo strain of Ebola The Independent · 10d ago
- Vaccines for the 2026 Bundibugyo Ebola disease outbreak: access gaps and recommendations ReliefWeb · 10d ago
- Moderna Ebola vaccine picked for Phase 2/3 trial (MRNA:NASDAQ) Seeking Alpha · 10d ago
- Two new candidate vaccines to join Ebola trial as treatment research advances World Health Organization (WHO) · 10d ago
- WHO approves trials for two new Ebola vaccines Al Jazeera · 10d ago
Topics
Related trends
U.S. loses measles-elimination status, erasing a landmark public health achievement
The United States has lost its measles-elimination status after 26 years, marking a major reversal in public health progress.
How Hamas shaped Gaza's winter flooding narrative before the first storm
International coverage converges on Gaza's winter flooding crisis as WHO warns of rising respiratory illness and displaced populations face deteriorating conditions in tent cities.
Ebola in DR Congo: Millions of dollars going missing as virus spreads, MSF warns
Millions of dollars are going missing as a rapid Ebola epidemic spreads across the Democratic Republic of Congo.
The Best Types of Puzzles to Keep Your Brain Sharp as You Age
Recent reporting examines the role of puzzles, daily activities, and cognitive training in supporting lifelong brain health and memory.
For Families of Those Who Died in the Iran War, a Veterans Day of Profound Loss
The New York Times marks Veterans Day 2026 with a front-page focus on families mourning service members killed in the Iran War, while five other outlets publish parallel reflections on conflict and remembrance.
Kenya's Ebola outbreak: Last patient discharged as countdown begins to be being declared free of the virus
Kenya discharges its final Ebola patient, initiating a 42-day countdown toward an official disease-free status declaration.